Safety
GLP-1 dosing safety: mg, mL, and syringe units
A prescription may describe milligrams, a vial may list mg/mL, and a syringe may have unit markings. Confusing those measures can produce a serious dosing error.
Four different pieces of information
Milligrams describe how much medicine is prescribed. Concentration describes how many milligrams are in each milliliter of liquid. Milliliters describe the volume to draw up. Syringe units describe markings on a particular syringe and do not inherently identify a medicine dose.
The relationship depends on both the vial concentration and the syringe. A change in pharmacy, formulation, vial size, or concentration can change the required volume even if the prescribed milligrams stay the same. Never reuse old unit instructions without checking.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
What FDA has observed
FDA has reported dosing errors with compounded semaglutide, including cases requiring medical attention. Confusion about measuring a dose can occur for patients and healthcare professionals, particularly when a product is supplied in a multidose vial rather than a prepared pen.
These reports support asking for clear instructions, not making a universal internet conversion chart. Keep the prescription, vial label, syringe specification, and pharmacist's written directions together. Confirm the intended dose with a pharmacist before injecting if any of them disagree.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
What to request from the pharmacy
Ask the pharmacist to state the prescribed milligrams, the vial concentration, the exact volume, and the specific syringe markings to use. Request a demonstration if the device is unfamiliar. Check the beyond-use date, storage, and instructions after opening.
If the pharmacy changes your concentration, ask for new written instructions before using the vial. Do not transfer a pen's dose-selection behavior to a syringe or assume that a familiar vial appearance means the formula is unchanged.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
If an error may have occurred
Contact the prescriber, pharmacist, or local poison-control service promptly if the wrong dose may have been taken. Seek urgent care for severe symptoms such as persistent vomiting, fainting, severe abdominal pain, or inability to keep fluids down.
Record the product, concentration, amount drawn, and time of injection without taking another dose to correct the situation. Report suspected adverse events or quality problems through FDA MedWatch when appropriate.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
How an unchanged dose can require a different volume
The arithmetic relationship is dose in milligrams divided by concentration in milligrams per milliliter, yielding volume in milliliters. This explains why concentration matters; it is not a syringe instruction. If the concentration changes while the prescribed milligrams stay the same, the required volume changes. The syringe markings add another device-specific step that the pharmacist must specify.
Imagine two vials labeled with different concentrations. Drawing the same visible volume from both does not necessarily deliver the same amount of medicine. A familiar-looking bottle or a prior message saying "use this many units" therefore cannot establish the new instruction. Request directions that connect the current prescription, current vial label, and supplied syringe in writing. Have the pharmacist demonstrate the measurement before injecting if any part is unclear.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
Resolve conflicting instructions before using the vial
Compare the prescription, pharmacy label, enclosed directions, and any portal message. If one uses milligrams while another gives syringe units without identifying the concentration and syringe, ask the pharmacy to reconcile them. Do not average conflicting instructions or choose whichever number seems familiar. A refill from a new pharmacy or a different formula should trigger a fresh check.
Also review storage, the beyond-use date, and handling after opening. A vial with added ingredients may have instructions that differ from an approved branded product. Do not use a pen's printed strength as a substitute for a vial concentration. If support staff answer a clinical measurement question, request confirmation from the dispensing pharmacist rather than relying solely on a billing or enrollment representative. Keep the clarified directions with the medicine.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
Prepare useful information if a dosing error is suspected
Gather the product name, pharmacy, ingredient list, concentration, syringe type, amount drawn, intended dose, and injection time. Keep the vial and packaging available. This information can help the clinician, pharmacist, poison-control service, or emergency team assess the exposure. Do not delay urgent care while trying to perfect the calculation or take another injection to compensate.
FDA has received reports of serious dosing errors with compounded semaglutide, including errors involving confusion between units, milligrams, and milliliters. Significant nausea, vomiting, fainting, dehydration, or severe abdominal pain after a possible error deserves prompt assessment. Once the immediate situation is addressed, ask for a corrected prescription and demonstration before the next dose. Reporting a suspected adverse event or quality problem through MedWatch can also help FDA track concerns.
Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss
Sources and evidence
Sources checked October 2, 2026. Prescribing information supports medication facts; provider pages support advertised services. Offers and labels can change.